Widespread shortages of cancer drugs are forcing doctors to make difficult decisions about how to treat their patients, including rationing doses and turning to other treatment options with potentially more side effects.
are forcing doctors to make difficult decisions about how to treat their patients, including rationing doses and turning to other treatment options with potentially more side effects.“The oncology shortage is especially critical,” FDA Commissioner Dr. Robert Califf told NBC News. “I’m a former intensivist doctor and I’m very aware of the consequences if you can’t get needed chemotherapy.”
“We have been rounding down for a while,” he said. “But we just ran out of the drugs, so there’s nothing to be rounded.” “Who’s going to be held accountable for this?” said Cherkinsky, who was diagnosed with ovarian cancer in March. “For me not getting the lifesaving treatment?” “One of the issues though with these alternative medications is often they’re not as good, so it may compromise survival outcomes,” said Dr. Angeles Alvarez Secord, president of the Society of Gynecologic Oncology.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Biden-Harris Administration Announces Proposal to Advance Prescription Drug Transparency in MedicaidThe Biden-Harris Administration has made lowering Rx drug costs in America a key priority. The new proposal would shed light on the actual cost of drugs covered by Medicaid, hold drug manufacturers accountable & save the program money!
Weiterlesen »
Former head of Arkansas State Medical Board raided by Drug Enforcement AdministrationA psychiatrist who stepped down as the head of the Arkansas State Medical Board in March was raided by the Drug Enforcement Administration Tuesday.
Weiterlesen »
Scientists use AI to find drug that kills bacteria responsible for many drug-resistant infectionsResearchers at MIT and McMaster University have identified a new drug that can kill a type of bacteria responsible for drug-resistant infections.
Weiterlesen »
Elon Musk's Neuralink gets FDA approval for study of brain implants in humansElon Musk's brain-implant company Neuralink on Thursday said it had received the U.S. Food and Drug Administration's (FDA) approval to launch its first-in-human clinical study.
Weiterlesen »
Neuralink gets FDA approval for ‘in-human’ trials of its brain-computer interfacePutting a chip in your brain and then putting it on the blockchain could finally provide immutable, digital proof of René Descartes' “cogito, ergo, sum” (I think, therefore I am).
Weiterlesen »
U.S. FDA approves Lexicon Pharma's drug for heart failureThe U.S. Food and Drug Administration (FDA) has approved Lexicon Pharmaceuticals Inc's drug for a broad treatment of heart failure, including in adult patients with type 2 diabetes, the company said on Friday.
Weiterlesen »